Back to top

BeOne Medicines upgraded to Buy from Hold at Jefferies

Jefferies upgraded BeOne Medicines (ONC) to Buy from Hold with a price target of $380, up from $333. The firm sees the company’s Brukinsa maintaini...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

BeOne Medicines Ltd. - Sponsored ADR (ONC)